Article

Better stromal bed quality with Zyoptix XP

The Zyoptix XP (Bausch & Lomb) microkeratome achieved increased stromal bed quality when compared with both standard and zero compression Hansatome heads (Bausch & Lomb), Thomas Hammer said.

The Zyoptix XP (Bausch & Lomb) microkeratome achieved increased stromal bed quality when compared with both standard and zero compression Hansatome heads (Bausch & Lomb), Thomas Hammer said.

Dr Hammer of the University Eye Hospital, Wittenberg, Germany, conducted an electron microscope evaluation of cutting edge and cut surface after lamellar keratotomy using both the XP and Hansatome.

The study evaluated both microkeratomes on freshly enucleated porcine eyes. There was a trial series of eight cuts with each model/head. After flap removal, an individualized score system was used to evaluate the cutting edge and stromal bed.

"The Hansatome is one of the most commonly used microkeratomes," said Dr Hammer. He added that the new Zyoptix XP is a new generation microkeratome developed from the Hansatome device and is based on the same pivoting principle as the Hansatome.

"Since the configuration of the cutting edge and the creation of the stromal bed has a potential impact on the refractive results, we examined those parameters," he said.

The cutting edge created by the Zyoptix XP microkeratome was steeper, leading to a shorter intraepithelial wound compared with the Hansatome. The demarcation of the cutting edge, or 'sharpness', was comparable to the Hansatome. But because the Zyoptix is 15% slower (4.6 mm/s) than the Hansatome with an equal oscillation of 1400 rpm/s, the stromal bed quality was smoother.

Dr Hammer concluded that increased stromal bed quality is achieved because of the changed oscillation and forward speed. The steeper cutting angle also decreases the risk of epithelial implantation.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.